Vanderbilt University

Running trials

• Not yet recruiting

  Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

  NCT07795593· Phase 4· Source

• Recruiting

  PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

  NCT07232069· Phase 3· Source

• Recruiting

  Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

  NCT07142252· Phase 2· Source

• Recruiting

  Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

  NCT06919224· Source

• Recruiting

  Discovery Diabetes

  NCT07116434· Source

• Recruiting

  OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels

  NCT06939751· Source

• Recruiting

  A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

  NCT07027514· Phase 1· Source

• Recruiting

  Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes

  NCT06482944· Source

• Recruiting

  A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

  NCT07043400· Phase 3· Source

• Recruiting

  Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

  NCT06750731· Source

• Recruiting

  Whole Foods for Teens: A Pilot Dietary Intervention to Reduce Body Adiposity in Adolescents With Obesity

  NCT06464497· Source

• Recruiting

  A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

  NCT06950034· Phase 1· Source

• Recruiting

  Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

  NCT06532890· Source

• Recruiting

  A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

  NCT06680830· Phase 2· Source

• Active, not recruiting

  Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

  NCT06538038· Source

• Active, not recruiting

  MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

  NCT06586515· Phase 1· Source

• Recruiting

  A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

  NCT06163534· Source

• Active, not recruiting

  A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

  NCT06285643· Phase 2· Source

• Active, not recruiting

  Sequential Therapy in Multiple Myeloma Guided by MRD Assessments

  NCT05231629· Phase 2· Source

• Active, not recruiting

  XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)

  NCT05881278· Source

• Active, not recruiting

  A Trial of Setmelanotide in Acquired Hypothalamic Obesity

  NCT05774756· Phase 3· Source

• Active, not recruiting

  A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

  NCT05608044· Phase 2· Source

• Active, not recruiting

  RESPONDER-HF Trial

  NCT05425459· Source

• Active, not recruiting

  Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  NCT05316701· Phase 3· Source

• Active, not recruiting

  A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

  NCT05199272· Phase 1/2· Source

• Enrolling by invitation

  Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies

  NCT05041309· Phase 2· Source

• Recruiting

  Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

  NCT03990896· Phase 2· Source

• Recruiting

  RA-PRO PRAGMATIC TRIAL

  NCT04692493· Phase 3· Source

• Recruiting

  Parkinson's Foundation PD GENEration Genetic Registry

  NCT04994015· Source

• Active, not recruiting

  A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors

  NCT04396821· Phase 1/2· Source

• Recruiting

  ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

  NCT04363684· Source

• Recruiting

  A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

  NCT04176198· Phase 1/2· Source

• Recruiting

  Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  NCT04198766· Phase 1/2· Source

• Active, not recruiting

  Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  NCT04013685· Phase 1· Source

• Active, not recruiting

  The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

  NCT03614260· Source

• Recruiting

  Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  NCT03715933· Phase 1· Source

• Active, not recruiting

  Ruxolitinib + Allogeneic Stem Cell Transplantation in AML

  NCT03286530· Phase 2· Source

• Active, not recruiting

  Interventions for Reading Disabilities in NF1

  NCT02964884· Phase 2· Source

• Active, not recruiting

  A Study of the ReCor Medical Paradise System in Clinical Hypertension

  NCT02649426· Source

• Recruiting

  Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  NCT01915511· Source

• Recruiting

  A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  NCT01351545· Source

• Active, not recruiting

  Insulin Detemir in Obesity Management

  NCT01239550· Source

• Active, not recruiting

  Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65

  NCT01208662· Phase 3· Source

• Active, not recruiting

  Improving Outcomes Assessment in Chronic GVHD

  NCT00637689· Source

• Recruiting

  TrialNet Pathway to Prevention of T1D

  NCT00097292· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers3 recruiting
• Type 1 diabetes3 recruiting
• Acute myeloid leukemia2 recruiting
• Chronic myeloid leukaemia2 recruiting
• Heart failure2 recruiting
• Parkinson disease2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• ALS (motor neurone disease)1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Frontotemporal dementia1 recruiting
• Gastric and esophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Hodgkin lymphoma1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Lung cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple myeloma1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Obesity1 recruiting
• Rheumatoid arthritis1 recruiting
• Sarcoma1 recruiting
• Sickle cell disease1 recruiting
• Type 2 diabetes1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Open-Label Extension Study of Setmelanotide

  NCT06596135· Phase 3· Source

• Withdrawn

  REVERSE-Long COVID-19 With Baricitinib Study

  NCT05858515· Phase 3· Source

• Completed

  A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

  NCT06159725· Phase 1/2· Source

• Terminated

  Sit Less Program for Patients With Type 2 Diabetes

  NCT06457802· Source

• Completed

  mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention

  NCT06059443· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Source

• Completed

  Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy

  NCT05178992· Source

• Completed

  Technology Based Sedentary Reduction Intervention in Patients With Type 2 Diabetes

  NCT05691452· Source

• Completed

  Testing a Family Service Navigator Program for Low-resourced Families of Young Children With Autism Spectrum Disorder

  NCT05099705· Source

• Terminated

  Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

  NCT05169437· Phase 2· Source

• Completed

  A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

  NCT04984356· Phase 1· Source

• Completed

  EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway

  NCT05093634· Phase 3· Source

• Completed

  Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training

  NCT04005794· Source

• Terminated

  A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy

  NCT04951609· Phase 1· Source

• Completed

  A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients

  NCT04075916· Phase 2· Source

• Completed

  XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer

  NCT04825288· Phase 1/2· Source

• Completed

  Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)

  NCT04880434· Phase 2· Source

• Completed

  Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation

  NCT04357288· Source

• Completed

  Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications

  NCT04419168· Source

• Completed

  Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

  NCT04423718· Phase 3· Source

• Completed

  Phase 1 Study of Oral TP-1454

  NCT04328740· Phase 1· Source

• Completed

  PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

  NCT04129931· Phase 2· Source

• Completed

  Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia

  NCT03836209· Phase 2· Source

• Completed

  STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA

  NCT03988309· Source

• Completed

  A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

  NCT03428958· Phase 1/2· Source

• Completed

  Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.

  NCT03427866· Phase 2· Source

• Completed

  Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

  NCT03375489· Source

• Withdrawn

  Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer

  NCT03419559· Phase 2· Source

• Recruiting

  Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

  NCT03016819· Phase 3· Source

• Completed

  A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment

  NCT02927769· Phase 2· Source

• Completed

  A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease

  NCT02836574· Phase 2· Source

• Completed

  Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging

  NCT02785848· Source

• Completed

  RNS® System Epilepsy Post-Approval Study

  NCT02403843· Source

• Completed

  Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

  NCT02108860· Phase 3· Source

• Terminated

  Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension

  NCT02245230· Phase 1· Source

• Completed

  Family Cognitive Behavioral Therapy for Preventing Depression in Children

  NCT00183482· Source

• Recruiting

  Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

  NCT02071134· Source

• Completed

  Vanderbilt Childhood Obesity Registry

  NCT02957916· Source

• Completed

  Effectiveness of Open and Robotic Prostatectomy

  NCT01325506· Source

• Completed

  Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer

  NCT00470704· Phase 2· Source

Trial sites

• Department of Urology,Vanderbilt University1 trial
• University of Vanderbilt1 trial
• Vanderbilt University72 trials
• Vanderbilt University Medical School1 trial
• Vanderbilt University (Neurology)1 trial
• Vanderbilt University School of Medicine7 trials
• Vanderbilt University School of Nursing2 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Obesity223 works · 6 trials
• HIV218 works · 1 trials
• Alzheimer disease213 works · 2 trials
• Heart failure204 works · 4 trials
• Colorectal cancer172 works · 5 trials
• Tuberculosis99 works · 0 trials
• Epilepsy81 works · 1 trials
• Schizophrenia70 works · 1 trials
• Autism43 works · 1 trials
• Triple-negative breast cancer32 works · 0 trials
• Type 1 diabetes29 works · 3 trials
• Kidney cancer26 works · 2 trials
• Head and neck cancer19 works · 3 trials
• Pulmonary arterial hypertension16 works · 0 trials
• Sickle cell disease16 works · 3 trials
• Idiopathic pulmonary fibrosis13 works · 1 trials
• Metastatic breast cancer12 works · 2 trials
• Myelodysplastic syndromes12 works · 3 trials
• Mesothelioma7 works · 0 trials
• Huntington's disease6 works · 0 trials
• Duchenne muscular dystrophy5 works · 0 trials